Edition:
United Kingdom

China Regenerative Medicine International Ltd (8158.HK)

8158.HK on Hong Kong Stock

0.17HKD
3:59am GMT
Change (% chg)

HK$-0.00 (-1.18%)
Prev Close
HK$0.17
Open
HK$0.17
Day's High
HK$0.17
Day's Low
HK$0.17
Volume
23,595,000
Avg. Vol
34,489,342
52-wk High
HK$0.31
52-wk Low
HK$0.16

Chart for

About

China Regenerative Medicine International Limited is a Hong Kong-based investment holding company principally engaged in the research and development of bio-medical and healthcare products. The Company operates through three business segments. The Tissue Engineering segment is engaged in the production and sales of tissue... (more)
No analyst recommendations are available for .

Overall

Beta: 1.77
Market Cap(Mil.): HK$3,429.23
Shares Outstanding(Mil.): 17,585.79
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-China Regenerative Medicine Informed That All Favour Intends To Dispose 2 Bln Shares Of Co

Jan 25 China Regenerative Medicine International Ltd:

25 Jan 2018

BRIEF-Baolingbao Biology's Unit Signs Agreement To Acquire 11.4 Pct Stake In China Regenerative Medicine

* SAYS UNIT SIGNS AGREEMENT TO BUY 2.0 BILLION SHARES IN CHINA REGENERATIVE MEDICINE INTERNATIONAL, OR 11.4 PERCENT STAKE, FOR HK$360 MILLION ($46.05 million) Source text in Chinese: http://bit.ly/2Dze5gs Further company coverage: ($1 = 7.8170 Hong Kong dollars) (Reporting by Hong Kong newsroom)

25 Jan 2018

BRIEF-China Regenerative Medicine International Says ‍Substantial Shareholder Ups Stake In Co

Jan 24 China Regenerative Medicine International Ltd:

24 Jan 2018

BRIEF-China Regenerative Medicine International Says Qtrly Revenue Hk$89 Million

Dec 8 China Regenerative Medicine International Ltd:

08 Dec 2017

BRIEF-China Regenerative Medicine International Says ‍Wong Sai Hung Resigned As Vice-Chairman

Nov 30 China Regenerative Medicine International Ltd:

30 Nov 2017

BRIEF-China Regenerative Medicine International say Dai Yumin acquired 40 pct stake in All Favour

Sept 21 China Regenerative Medicine International Ltd

21 Sep 2017

BRIEF-China Regenerative Medicine International re-designates Ray Yip to an executive director

Sept 8 China Regenerative Medicine International Ltd:

08 Sep 2017

BRIEF-China Regenerative Medicine International Group updates on product expansion

Sept 5 China Regenerative Medicine International Ltd:

05 Sep 2017

Earnings vs. Estimates

No consensus analysis data available.